No Data
No Data
LONGEVERON Earnings Preview: Recent $LGVN Insider Trading, Hedge Fund Activity, and More
Longeveron Management to Meet With Maxim
Earnings Preview: Longeveron to Report Financial Results Post-market on February 28
Longeveron to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025
Longeveron Cellular Therapy Granted International Non-Proprietary Name
Express News | Longeveron® Announces World Health Organization Approval of “Laromestrocel” as International Non-Proprietary Name for Stem Cell Therapy Lomecel-B™